A Case of Nivolumab-Induced Bullous Pemphigoid-Successfully Treated with Rituximab. [PDF]
J Community Hosp Intern Med PerspectAmin R, Ranpura N, Hatic H.
europepmc +1 more source
Dupilumab enables glucocorticoid withdrawal in refractory multisite mucous membrane pemphigoid: a case report. [PDF]
Front Med (Lausanne)Hu Y, Xu LL, Li KH, Yu CS, Wang SB.
europepmc +1 more source
Dupilumab for Drug-Induced Bullous Pemphigoid: A Case Series and Literature Review. [PDF]
Clin Cosmet Investig DermatolSakpuwadol N +3 more
europepmc +1 more source
Abrocitinib and dupilumab bridging therapy for bullous pemphigoid with insufficient response to initial corticosteroid therapy: a case report. [PDF]
Front ImmunolZhang H, Li L, Zhao S, Wu H, Zhu J.
europepmc +1 more source
Commentary: Pemphigoid associated with quinolone antibiotics: a real-world pharmacovigilance study of the FDA adverse event reporting system and literature-based evidence. [PDF]
Front ImmunolLin HH, Mao KL, Li LC, Zhou HH.
europepmc +1 more source
Autoimmune bullous disease in skin of color: A case series
JAAD Case Reports, 2020 Shant Tamazian, BS +1 more
doaj +1 more source
Delayed-Onset Localized Bullous Pemphigoid on an Umbilical Hernia Repair Scar: An Example of Ruocco's Immunocompromised Cutaneous District. [PDF]
CureusTercan E +4 more
europepmc +1 more source
Esophageal involvement in bullous pemphigoid: A case of blisters impeding oral intake. [PDF]
J Hosp MedBarton N, Newman S.
europepmc +1 more source
Diagnostic Accuracy of Multimodal Large Language Models for Four-Class Benchmark of Oral Autoimmune Blistering Diseases: A Multicenter Paired Study. [PDF]
Diagnostics (Basel)Abou-Bakr A +6 more
europepmc +1 more source